Tag: rituximab biosimilar
Monoclonal Antibody Biosimilars: Examples and Clinical Uses
Monoclonal antibody biosimilars offer proven, cost-effective alternatives to expensive biologic drugs like Herceptin and Rituxan. With multiple FDA-approved examples and real-world data showing safety and savings, they're transforming cancer and autoimmune care.
Continue Reading